Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1099)	4/15/2002 10:09:46 AM
From: Michael Bakunin	Read Replies (2) \| Respond to of 2243

Today I may (knock on wood) be able to buy TLRK with a $12 handle, which makes me more sanguine about T67 at ASCO, not to mention about the risk profile of an investment at the lower price. They tell you not to catch a falling knife, but... I'm also tempted by INCY at this point. Tell me to resist, please. Still, I've halfway convinced myself to wait on TLRK 'til the news is out, rather than just a rumor, even if I have to pay a little more for the eventual certainty. Everyone seems to have ASCO abstracts, why don't we? -mb